The role of invariant natural killer T cells and associated immunoregulatory factors in triptolide-induced cholestatic liver injury

Mengzhi Zou,Cheng Nong,Zixun Yu,Heng Cai,Zhenzhou Jiang,Rufeng Xue,Xin Huang,Lixin Sun,Luyong Zhang,Xinzhi Wang

DOI: https://doi.org/10.1016/j.fct.2020.111777

IF: 4.3

2020-12-01

Food and Chemical Toxicology

Abstract:<p>Proinflammatory cytokines are potent inhibitors of bile acid nuclear receptors and transporters. Triptolide (TP), an active ingredient of <em>Tripterygium wilfordii</em> Hook. f, exhibits unique efficacy for autoimmune diseases and tumors. While its clinical application is greatly constrained by hepatotoxicity. Therefore, we explored the mechanism of iNKT cells and associated immunoregulators in TP-induced cholestatic liver injury. TP was administered to both female C57BL/6 mice and Jα18^−/− mice. INKT cells released significantly increased Th2 cytokine IL-4 in C57BL/6 mice after TP administration. Blood biochemistry, histopathology and immunohistochemistry demonstrated that TP-induced cholestasis liver injury. In Jα18^−/− mice, cholestatic liver damage was alleviated due to the upregulation of type 2 NKT cells, nuclear receptor FXR, transporter OATP1B2 and CYP450, but also the downregulation of <em>Cxcl10</em>, ICAM-1 and Egr-1. Above results suggested that Th2 cytokines produced by iNKT cells suppressed type 2 NKT cells and promoted the expression of immunoregulatory factors represented by CXCL10, ICAM-1 and Egr-1, which in turn affected cholestasis-related nuclear receptor, transporter and enzymes, thus aggravated cholestatic liver injury. Our research contributes to better understanding of the role of iNKT cells in TP-induced cholestatic liver injury, thereby providing potential therapeutic targets for clinical prevention and treatment.</p>

toxicology,food science & technology